Highlights and Quick Summary
- Net Current Asset Value for the quarter ending September 30, 2022 was $-292 Million (a 27.67% increase compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value increased by 126.55%
- Annual Net Current Asset Value for 2021 was $-129 Million (a 327.48% increase from previous year)
- Annual Net Current Asset Value for 2020 was $-30.2 Million (a -210.48% decrease from previous year)
- Annual Net Current Asset Value for 2019 was $27.3 Million (a 63.11% increase from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of BioCryst Pharmaceuticals, Inc.
Most recent Net Current Asset Valueof BCRX including historical data for past 10 years.Interactive Chart of Net Current Asset Value of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-292.25 | $-228.92 | $-180.22 | – |
| 2021 | $-129.0 | $-160.06 | $-117.56 | $-85.65 | $-129.0 |
| 2020 | $-30.18 | $19.85 | $65.64 | $-7.43 | $-30.18 |
| 2019 | $27.32 | $-52.95 | $-21.82 | $-2.18 | $27.32 |
| 2018 | $16.75 | $33.06 | $2.21 | $10.84 | $16.75 |
| 2017 | $30.9 | $84.51 | $2.83 | $22.52 | $30.9 |
| 2016 | $-21.28 | $-22.88 | $-22.72 | $-24.66 | $-21.28 |
| 2015 | $-10.84 | $9.59 | $33.0 | $15.87 | $-10.84 |
| 2014 | $28.1 | $81.47 | $86.36 | $-13.38 | $28.1 |
| 2013 | $-7.87 | $-2.96 | $-15.43 | $-14.33 | $-7.87 |
| 2012 | $-15.92 | $-7.73 | $-15.51 | $-3.99 | $-15.92 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology